Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "mental"

1138 News Found

Evonik bets €80 million on biotech expansion to power next-gen pharma growth
Biotech | April 23, 2026

Evonik bets €80 million on biotech expansion to power next-gen pharma growth

The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances


Crown Bioscience partners with Turbine to accelerate translational oncology research
R&D | April 22, 2026

Crown Bioscience partners with Turbine to accelerate translational oncology research

The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems


New brain study reveals why alcohol relapse remains a persistent challenge
R&D | April 22, 2026

New brain study reveals why alcohol relapse remains a persistent challenge

These findings help explain how relapse-triggering memories can persist alongside those that support recovery


ECI taps industry veteran Khalid Raja to drive strategic growth
People | April 22, 2026

ECI taps industry veteran Khalid Raja to drive strategic growth

Move comes amid rising regulatory pressures


Pfizer unleashes wave of breakthrough cancer data at ASCO 2026
R&D | April 22, 2026

Pfizer unleashes wave of breakthrough cancer data at ASCO 2026

Pharma giant targets new standards of care


Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%
Sustainability | April 22, 2026

Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%

Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials


Blueneem Medical Devices  appoints Manoj Tumkur Venkatachala as Chief Product Officer
People | April 22, 2026

Blueneem Medical Devices appoints Manoj Tumkur Venkatachala as Chief Product Officer

Manoj has over two decades of experience in healthcare operations and biomedical engineering


Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
Clinical Trials | April 22, 2026

Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%

The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints


BioMed X launches AI-driven bispecific antibody research team in France
Biotech | April 21, 2026

BioMed X launches AI-driven bispecific antibody research team in France

The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation


India Autism Center highlights inclusive residential care at ALFOC Conclave 2026
Healthcare | April 21, 2026

India Autism Center highlights inclusive residential care at ALFOC Conclave 2026

The conclave brought together key stakeholders from across the assisted living ecosystem